Home » Topics » Regulatory » Patents

Patents
RSS

Tanabe Seiyaku reveals new ET antagonists

June 3, 1997

Nippon Kayaku discovers new antitumor agent

June 3, 1997

Orally active antiplatelet agents described by Taisho

June 3, 1997

Lilly prepares new 5-HT1F agonists

June 3, 1997

Suntory presents new glutamate receptor antagonists

June 3, 1997

AGE inhibitor described by Kissei

June 3, 1997

CAAX-based protein farnesyltransferase inhibitors from Merck & Co.

June 3, 1997

Ludwig Institute describes new tumor rejection antigens

June 3, 1997

Antiallergic/antiasthmatic agents from Sumitomo Metal

June 2, 1997

Lilly describes agents for Alzheimer's disease

June 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...